scholarly article | Q13442814 |
P2093 | author name string | Henry H Wortis | |
Iris Z Jaffe | |||
Pilar Alcaide | |||
Nicholas C Bene | |||
P2860 | cites work | Refining the role of B cells in atherosclerosis | Q84379092 |
Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes | Q87091235 | ||
Aging-associated cardiovascular changes and their relationship to heart failure | Q27024178 | ||
Alternative activation of macrophages | Q27860939 | ||
Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated | Q28281477 | ||
Mechanisms of mineralocorticoid action | Q28281657 | ||
The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators | Q28372091 | ||
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 | Q28585931 | ||
The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation | Q29617813 | ||
Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors | Q30528005 | ||
Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction | Q33642021 | ||
T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses | Q33819043 | ||
Mineralocorticoid action. | Q33819647 | ||
Mineralocorticoid selectivity: molecular and cellular aspects | Q33888900 | ||
Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway | Q33903180 | ||
The role of aldosteronism in causing obesity-related cardiovascular risk | Q33995992 | ||
The role of inflammatory and fibrogenic pathways in heart failure associated with aging. | Q34061245 | ||
Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. | Q34090097 | ||
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction | Q34187441 | ||
Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells | Q34331407 | ||
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein | Q34390132 | ||
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol | Q34522261 | ||
Inflammation, immunity, and hypertension | Q34528283 | ||
Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators | Q34539986 | ||
Myeloid-specific deletion of the mineralocorticoid receptor reduces infarct volume and alters inflammation during cerebral ischemia | Q34591546 | ||
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure | Q34620874 | ||
Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications | Q34684861 | ||
Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research | Q34788452 | ||
Foxp3+-inducible regulatory T cells suppress endothelial activation and leukocyte recruitment | Q35552966 | ||
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction | Q36229028 | ||
Expanding the effector CD4 T-cell repertoire: the Th17 lineage. | Q36449975 | ||
Mineralocorticoid and glucocorticoid receptors differentially regulate NF-kappaB activity and pro-inflammatory cytokine production in murine BV-2 microglial cells | Q36478492 | ||
Adaptive immunity in atherogenesis: new insights and therapeutic approaches | Q36497196 | ||
Aldosterone increases early atherosclerosis and promotes plaque inflammation through a placental growth factor-dependent mechanism | Q36701794 | ||
Mechanisms of cardiac fibrosis in hypertension | Q36873139 | ||
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion | Q37003229 | ||
Regulation of T-cell function by endogenously produced angiotensin II. | Q37100479 | ||
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice | Q37368296 | ||
11β-hydroxysteroid dehydrogenase type 2 deficiency accelerates atherogenesis and causes proinflammatory changes in the endothelium in apoe-/- mice | Q37687153 | ||
Role of the adaptive immune system in hypertension | Q37694853 | ||
Mechanisms of cardiac fibrosis in inflammatory heart disease. | Q37743971 | ||
Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells | Q37849362 | ||
Mineralocorticoid receptors in vascular function and disease | Q37896953 | ||
Immune modulation of resistance artery remodelling | Q37899280 | ||
Protective role of natural IgM-producing B1a cells in atherosclerosis | Q38030251 | ||
The immune system: role in hypertension | Q38035608 | ||
Smooth muscle cell mineralocorticoid receptors: role in vascular function and contribution to cardiovascular disease | Q38103479 | ||
IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1/2-dependent C/EBP-beta , NF-kappaB, and AP-1 activation | Q38297511 | ||
Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells | Q38330461 | ||
Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone | Q40559994 | ||
Systemic administration of autologous, alloactivated helper-enriched lymphocytes to patients with metastatic melanoma of the lung. A phase I study. | Q40812995 | ||
Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension | Q41956748 | ||
Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure | Q42457579 | ||
The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure | Q42468951 | ||
Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. | Q42829877 | ||
Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. | Q43233439 | ||
Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study | Q43691886 | ||
Eplerenone in patients with systolic heart failure and mild symptoms | Q44272913 | ||
Effect of eplerenone, a selective aldosterone blocker, on blood pressure, serum and macrophage oxidative stress, and atherosclerosis in apolipoprotein E-deficient mice | Q44459362 | ||
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study | Q44601096 | ||
Distinguishing the antihypertensive and electrolyte effects of eplerenone | Q44924306 | ||
IL-17 induces myocardial fibrosis and enhances RANKL/OPG and MMP/TIMP signaling in isoproterenol-induced heart failure. | Q45968562 | ||
Critical role of macrophages in glucocorticoid driven vascular calcification in a mouse-model of atherosclerosis | Q46372665 | ||
A Nuclear Receptor Atlas: macrophage activation | Q46506122 | ||
Macrophage mineralocorticoid receptor signaling plays a key role in aldosterone-independent cardiac fibrosis | Q47677228 | ||
Regulatory T cells ameliorate angiotensin II-induced cardiac damage | Q47721821 | ||
Aldosterone, mortality, and acute ischaemic events in coronary artery disease patients outside the setting of acute myocardial infarction or heart failure | Q49106538 | ||
Lentivirus mediated IL-17R blockade improves diastolic cardiac function in spontaneously hypertensive rats. | Q50521732 | ||
Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. | Q50761727 | ||
Widespread Myocardial Inflammation and Infarct-Related Artery Patency | Q58230268 | ||
Local Amplification of Glucocorticoids by 11 -Hydroxysteroid Dehydrogenase Type 1 Promotes Macrophage Phagocytosis of Apoptotic Leukocytes | Q61865359 | ||
Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor | Q67494059 | ||
Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen | Q69833633 | ||
Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism | Q81661632 | ||
T regulatory lymphocytes prevent aldosterone-induced vascular injury | Q82831987 | ||
T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury | Q83288251 | ||
Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in mice | Q83567632 | ||
P921 | main subject | cardiovascular disease | Q389735 |
P304 | page(s) | 38-45 | |
P577 | publication date | 2014-04-21 | |
P1433 | published in | Steroids | Q15716675 |
P1476 | title | Mineralocorticoid receptors in immune cells: emerging role in cardiovascular disease. | |
P478 | volume | 91 |